NLH — Nova Leap Health Share Price
0.000.00%
Last trade - 00:00- CA$21.39m
- CA$22.95m
- $25.76m
- 81
- 89
- 79
- 97
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.85 | ||
| Price to Tang. Book | 9.4 | ||
| Price to Free Cashflow | 11.33 | ||
| Price to Sales | 0.6 | ||
| EV to EBITDA | 13.58 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.32% | ||
| Return on Equity | 7.56% | ||
| Operating Margin | 2.47% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 17.31 | 21.28 | 28.21 | 26.18 | 25.76 | n/a | n/a | 8.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nova Leap Health Corp. is a Canada-based acquisitive home health care services company operating in the United States (U.S.) and Canada. The Company, through its subsidiaries, provides various services to clients and families, including dementia care, companionship, personal care, respite care, cooking and meal preparation, light housekeeping, activities of daily living (ADL), transportation services, medication reminders, and medication administration by nursing staff. Its supportive services can be arranged for any frequency of time, from one to twenty-four hours of care daily, or on a respite or temporary basis. The Company's services can be funded through a variety of sources, including Medicaid waiver programs, long-term care insurance, veterans benefits, private pay and other location-specific social service programs. It operates in approximately eight different U.S. states within the New England, Southeastern, South-Central and Midwest regions as well as Nova Scotia, Canada.
Directors
- Dana Hatfield NEC
- Christopher Dobbin PRE (43)
- Megan Spidle CFO
- Marie Mullally IND
- Wayne Myles IND
- Michael O'keefe IND (51)
- Anne Whelan IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 16th, 2015
- Public Since
- February 19th, 2016
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 87,314,252
- Address
- 7071 Bayers Road, Suite 3006, HALIFAX, B3L 2C2
- Web
- https://novaleaphealth.com/
- Phone
- +1 9024019480
- Auditors
- Grant Thornton LLP
Upcoming Events for NLH
Nova Leap Health Corp Annual Shareholders Meeting
Nova Leap Health Corp Annual Shareholders Meeting
Q2 2025 Nova Leap Health Corp Earnings Release
Similar to NLH
AJA Health And Wellness
TSX Venture Exchange
ARCpoint
TSX Venture Exchange
Cannara Biotech
TSX Venture Exchange
Element Lifestyle Retirement
TSX Venture Exchange
Jack Nathan Medical
TSX Venture Exchange
FAQ
What is the Nova Leap Health share price?
As of Today at 04:21 UTC, shares in Nova Leap Health are trading at CA$0.25. This share price information is delayed by 15 minutes.
How has the Nova Leap Health share price performed this year?
Shares in Nova Leap Health last closed at CA$0.25 and the price had moved by +8.89% over the past 365 days. In terms of relative price strength the Nova Leap Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -3.19% over the past year.
What are the analyst and broker recommendations for Nova Leap Health?
The overall consensus recommendation for Nova Leap Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Nova Leap Health dividend yield?
Nova Leap Health does not currently pay a dividend.
Does Nova Leap Health pay a dividend?
Nova Leap Health does not currently pay a dividend.
When does Nova Leap Health next pay dividends?
Nova Leap Health does not currently pay a dividend.
How do I buy Nova Leap Health shares?
To buy shares in Nova Leap Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nova Leap Health?
As of the previous close price of CA$0.25, shares in Nova Leap Health had a market capitalisation of CA$21.39m.
Where are Nova Leap Health shares listed?
Here are the trading details for Nova Leap Health:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: NLH
What kind of share is Nova Leap Health?
Based on an overall assessment of its quality, value and momentum Nova Leap Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nova Leap Health share price forecast for 2025?
The analyst consensus target price for shares in Nova Leap Health is CA$0.60. That is 144.9% above the last closing price of CA$0.25.
Analysts covering Nova Leap Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Nova Leap Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nova Leap Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -21.43%.
As of the last closing price of CA$0.25, shares in Nova Leap Health were trading -9.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nova Leap Health PE Ratio?
The Nova Leap Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nova Leap Health?
Nova Leap Health's management team is headed by:
- Dana Hatfield - NEC
- Christopher Dobbin - PRE
- Megan Spidle - CFO
- Marie Mullally - IND
- Wayne Myles - IND
- Michael O'keefe - IND
- Anne Whelan - IND